Search

Showing total 2 results
Start Over Topic digestive system neoplasms
2 results

1. 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies

Author

Richard L. Wahl and Bennett B. Chin

Subjects
Adult, Male, Paper, Pathology, medicine.medical_specialty, Esophageal Neoplasms, Digestive System Neoplasms, Fluorodeoxyglucose F18, Stomach Neoplasms, medicine, Humans, Colonic disease, medicine.diagnostic_test, business.industry, Deoxyglucose, Gastroenterology, Middle Aged, Pancreatic Neoplasms, Positron emission tomography, Female, Radiopharmaceuticals, Colorectal Neoplasms, Nuclear medicine, business, Rectal disease, Biliary tract disease, Tomography, Emission-Computed
Abstract

Positron emission tomography with (18)F-fluoro-2-deoxyglucose is an imaging technology that is demonstrating increasing utility in the evaluation of gastrointestinal malignancies.

Published
2003
Full Text
View/download PDF

2. The promise of gene therapy in gastrointestinal and liver diseases

Author

Cheng Qian, Bruno Sangro, Juan Carlos Ruiz, Guillermo Mazzolini, Ignacio Melero, Maite Herraiz, and Jesús Prieto

Subjects
Gastrointestinal Diseases/therapy, Paper, medicine.medical_specialty, Cirrhosis, Hepatitis, Viral, Human, Gastrointestinal Diseases, Genetic enhancement, Digestive System Neoplasms, Inflammatory bowel disease, Gastroenterology, Internal medicine, medicine, Animals, Humans, Gastrointestinal tract, business.industry, Liver Diseases, Genetic Therapy, Hepatology, medicine.disease, Inflammatory Bowel Diseases, Ulcerative colitis, Liver Diseases/therapy, medicine.anatomical_structure, Gene Therapy/methods, Chronic Disease, Pancreas, business, Viral hepatitis
Abstract

Gene therapy consists of the transfer of genetic material to cells to achieve a therapeutic goal. In the field of gastroenterology and hepatology gene therapy has produced considerable expectation as a potential tool in the management of conditions that lack effective therapy including non-resectable neoplasms of the liver, pancreas and gastrointestinal tract, chronic viral hepatitis unresponsive to interferon therapy, liver cirrhosis, and inflammatory bowel disease.